Viewing nowTelmisartan Tablets 40 mg (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
Green Cross Corp.

MFDS item code 201003095 · Notified 2010.04.27 · Insurance code 644501760
Treatment of essential hypertension; prevention of cardiovascular diseases (including myocardial infarction and stroke)
This medication is primarily used for patients with essential hypertension. It also helps reduce the risk of cardiovascular disease in high-risk diabetic patients aged 55 and older with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attacks, or evidence of target organ damage. This drug is effective in reducing the risk of death related to cardiovascular events such as myocardial infarction and stroke. It can be administered tolerably to patients for whom ACE inhibitors are difficult to use. Therefore, it is effectively used to reduce the risk of essential hypertension and cardiovascular diseases.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This drug has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This drug can cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be taken by individuals who are allergic to it or its ingredients, pregnant or breastfeeding women, people with severe liver impairment or bile duct obstruction, patients with hereditary angioedema, and those with certain kidney diseases. Elderly patients, those with high serum potassium levels, individuals with mild to moderate liver impairment, heart valve disease, cardiovascular disease, gastrointestinal disease, renal artery hypertension, and patients with severely impaired kidney function should take this medication with caution. This medication may cause various adverse reactions such as hyperkalemia, renal dysfunction, hypotension, allergic reactions, and liver function abnormalities, so it is important to monitor symptoms during use and consult a doctor immediately if adverse symptoms occur. In particular, if symptoms such as a sudden drop in blood pressure, dizziness, fainting, dyspnea, and swelling of the face, lips, or tongue occur, immediate medical treatment should be sought. Patients with renal impairment or those who have undergone kidney transplantation should have their potassium and creatinine levels monitored regularly. In cases of low blood volume or sodium depletion, there is a risk of hypotension, so conditions should be corrected before taking this medication. When taken with other antihypertensive agents, the blood pressure-lowering effect may be increased, and there may be a risk of renal function deterioration or hyperkalemia when taken with specific drugs, so current medications must be reported to the doctor. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women should avoid taking it or interrupt breastfeeding. Children under 18 years should not use this medication as its safety and efficacy are not established. Elderly patients should take the medication carefully to prevent excessively low blood pressure and be aware of dizziness or fainting during use. In cases of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, necessitating immediate medical attention for appropriate treatment. This medication should be stored out of reach of children and kept sealed until just before use to protect its quality. Caution should be exercised while driving or operating dangerous machinery as there may be a risk of dizziness or fainting due to hypotensive effects.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from exposure to air or moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness of the medication and ensure safe usage.
White or off-white oval tablets
30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
Green Cross Corp.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.